| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000031724 |
| Receipt No. | R000036229 |
| Official scientific title of the study | A systematic review and meta-analysis of lipid-lowering therapy using contemporary high-intensity agents for high-risk atherosclerotic patients |
| Date of disclosure of the study information | 2018/04/30 |
| Last modified on | 2018/05/02 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A systematic review and meta-analysis of lipid-lowering therapy using contemporary high-intensity agents for
high-risk atherosclerotic patients |
|
| Title of the study (Brief title) | A systematic review and meta-analysis of lipid-lowering therapy using contemporary high-intensity agents for
high-risk atherosclerotic patients |
|
| Region |
|
|
| Condition | |||
| Condition | Patients with atherosclerotic risk | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | What is the most effective/safe high-intensity lipid-lowering therapy for patients with high atherosclerotic risk?
|
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Major adverse cardiovascular events. |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Randomized controlled trials comparing the more- and less- intensity LLT on clinical outcomes for the patients with atherosclerotic cardiovascular risk. | |||
| Key exclusion criteria | Reports with insufficient quality for the data synthesis. | |||
| Target sample size | 100000 | |||
| Research contact person | |
| Name of lead principal investigator | Takeshi Kimura |
| Organization | Kyoto University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 54 Shogoinkawaharacho, Sakyo-ku, Kyoto |
| TEL | 81-75-751-4255 |
| totoyota@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Toshiaki Toyota |
| Organization | Kyoto University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 54 Shogoinkawaharacho, Sakyo-ku, Kyoto |
| TEL | 81-75-751-4255 |
| Homepage URL | |
| totoyota@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Kyoto University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kyoto University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Using Medline, The Cochrane Library, ClinicalTrials.gov, and Conference proceedings, eligible RCTs will be extracted for the data synthesis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036229 |